Daniel Mihalik

Dr. Daniel Mihalik


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LSLiliana Schaefer
Liliana Schaefer
ABAndrea Babelova
Andrea Babelova
EKEva Kiss
Eva Kiss
HHHeinz-J. Hausser
Heinz-J. Hausser
MBMartina Baliova
Martina Baliova
HGHermann-Josef Gröne
Hermann-Josef Gröne
Biglycan, a small leucine-rich proteoglycan, is a ubiquitous ECM component; however, its biological role has not been elucidated in detail. Here we show that biglycan acts in macrophages as an endogenous ligand of TLR4 and TLR2, which mediate innate immunity, leading to rapid activation of p38, ERK, and NF-κB and thereby stimulating the expression of TNF-α and macrophage inflammatory protein–2 (MIP-2). In agreement, the stimulatory effects of biglycan are significantly reduced in TLR4-mutant (TLR4-M), TLR2–/–, and myeloid differentiation factor 88–/– (MyD88–/–) macrophages and completely abolished in TLR2–/–/TLR4-M macrophages. Biglycan-null mice have a considerable survival benefit in LPS- or zymosan-induced sepsis due to lower levels of circulating TNF-α and reduced infiltration of mononuclear cells in the lung, which cause less end-organ damage. Importantly, when stimulated by LPS-induced proinflammatory factors, macrophages themselves are able to synthesize biglycan. Thus, biglycan, upon release from the ECM or from macrophages, can boost inflammation by signaling through TLR4 and TLR2, thereby enhancing the synthesis of TNF-α and MIP-2. Our results provide evidence for what is, to our knowledge, a novel role of the matrix component biglycan as a signaling molecule and a crucial proinflammatory factor. These findings are potentially relevant for the development of new strategies in the treatment of sepsis.

25 May 2020 in Plants
Verified
Journal Article
Open access
PDF file
RHRichard Hančinský
Richard Hančinský
DMDaniel Mihalik
Daniel Mihalik
MMMichaela Mrkvová
Michaela Mrkvová
TCThierry Candresse
Thierry Candresse
MGMiroslav Glasa
Miroslav Glasa
Plant viruses infecting crop species are causing long-lasting economic losses and are endangering food security worldwide. Ongoing events, such as climate change, changes in agricultural practices, globalization of markets or changes in plant virus vector populations, are affecting plant virus life cycles. Because farmer’s fields are part of the larger environment, the role of wild plant species in plant virus life cycles can provide information about underlying processes during virus transmission and spread. This review focuses on the Solanaceae family, which contains thousands of species growing all around the world, including crop species, wild flora and model plants for genetic research. In a first part, we analyze various viruses infecting Solanaceae plants across the agro-ecological interface, emphasizing the important role of virus interactions between the cultivated and wild zones as global changes affect these environments on both local and global scales. To cope with these changes, it is necessary to adjust prophylactic protection measures and diagnostic methods. As illustrated in the second part, a complex virus research at the landscape level is necessary to obtain relevant data, which could be overwhelming. Based on evidence from previous studies we conclude that Solanaceae plant communities can be targeted to address complete life cycles of viruses with different life strategies within the agro-ecological interface. Data obtained from such research could then be used to improve plant protection methods by taking into consideration environmental factors that are impacting the life cycles of plant viruses.

1 August 2004 in The American Journal of Pathology
Verified
Journal Article
Closed access
LSLiliana Schaefer
Liliana Schaefer
DMDaniel Mihalik
Daniel Mihalik
ABAndrea Babelova
Andrea Babelova
MKMiroslava Krzyzankova
Miroslava Krzyzankova
HGHermann-Josef Gröne
Hermann-Josef Gröne
RSRoland M. Schaefer
Roland M. Schaefer

1 July 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
LSLiliana Schaefer
Liliana Schaefer
KBKarl-Friedrich Beck
Karl-Friedrich Beck
IRIgor Raslik
Igor Raslik
SWSebastian Walpen
Sebastian Walpen
DMDaniel Mihalik
Daniel Mihalik
JPJosef Pfeilschifter
Josef Pfeilschifter
During glomerular inflammation mesangial cells are the major source and target of nitric oxide that pro-foundly influences proliferation, adhesion, and death of mesangial cells. The effect of nitric oxide on the mRNA expression pattern of cultured rat mesangial cells was therefore investigated by RNA-arbitrarily-primed polymerase chain reaction. Employing this approach, biglycan expression turned out to be down-regulated time- and dose-dependently either by interleukin-1beta-stimulated endogenous nitric oxide production or by direct application of the exogenous nitric oxide donor, diethylenetriamine nitric oxide. There was a corresponding decline in the rate of biglycan biosynthesis and in the steady state level of this proteoglycan. In vivo, in a model of mesangioproliferative glomerulonephritis up-regulation of inducible nitric-oxide synthase mRNA was associated with reduced expression of biglycan in isolated glomeruli. Biglycan expression could be normalized, both in vitro and in vivo, by using a specific inhibitor of the inducible nitric-oxide synthase, l-N6-(l-iminoethyl)-l-lysine dihydrochloride. Further studies showed that biglycan inhibited cell adhesion on type I collagen and fibronectin because of its binding to these substrates. More importantly, biglycan protected mesangial cells from apoptosis by decreasing caspase-3 activity, and it counteracted the proliferative effects of platelet-derived growth factor-BB. These findings indicate a signaling role of biglycan and describe a novel pathomechanism by which nitric oxide modulates the course of renal glomerular disease through regulation of biglycan expression.

5 March 2021 in Plants
Verified
Journal Article
Open access
PDF file
MSMartin Sák
Martin Sák
IDIvana Dokupilová
Ivana Dokupilová
ŠKŠarlota Kaňuková
Šarlota Kaňuková
MMMichaela Mrkvová
Michaela Mrkvová
DMDaniel Mihalik
Daniel Mihalik
JKJán Kraic
Ján Kraic
The in vitro cell cultures derived from the grapevine (Vitis vinifera L.) have been used for the production of stilbenes treated with different biotic and abiotic elicitors. The red-grape cultivar Váh has been elicited by natural cellulose from Trichoderma viride, the cell wall homogenate from Fusarium oxysporum and synthetic jasmonates. The sodium-orthovanadate, known as an inhibitor of hypersensitive necrotic response in treated plant cells able to enhance production and release of secondary metabolite into the cultivation medium, was used as an abiotic elicitor. Growth of cells and the content of phenolic compounds trans-resveratrol, trans-piceid, δ-viniferin, and ɛ-viniferin, were analyzed in grapevine cells treated by individual elicitors. The highest accumulation of analyzed individual stilbenes, except of trans-piceid has been observed after treatment with the cell wall homogenate from F. oxysporum. Maximum production of trans-resveratrol, δ- and ɛ-viniferins was triggered by treatment with cellulase from T. viride. The accumulation of trans-piceid in cell cultures elicited by this cellulase revealed exactly the opposite effect, with almost three times higher production of trans-resveratrol than that of trans-piceid. This study suggested that both used fungal elicitors can enhance production more effectively than commonly used jasmonates.

27 August 2013 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
MČMilan Čertík
Milan Čertík
TKTatiana Klempová
Tatiana Klempová
LGLucia Guothová
Lucia Guothová
DMDaniel Mihalik
Daniel Mihalik
JKJán Kraic
Ján Kraic